topic: Access to Medicines

Dozens of volunteers from MSF delivered a petition with the names of nearly 400,000 people to Pfizer global headquarters in New York, asking to reduce the price of the pneumonia vaccine to $5 per child in developing countries. Photo: Edwin Torres
Investors join MSF in calling Pfizer to Reduce the price of vaccine against top childhood killer
Children are vaccinated during the first day of a Measles vaccination programme in Conakry, the capital of Guinea. Photo: Markel Redondo
Guinea: Battling a large scale measles epidemic
MSF joins Europe-wide action challenging patent on key hepatitis C drug
The vaccine is made by the Serum Institute of India using five strains of the virus collected exclusively in Sub-Saharan Africa. Photo: Séverine Bonnet/MSF
Niger: Innovative vaccine could prevent thousands of child deaths from diarrhoea
Photo: Alexis Huguet/MSF
India–EFTA trade talks may make medicines more expensive
MSF calls on Japan and South Korea to drop the harmful RCEP measures
Health groups call on Government of India to urgently make lifesaving TB drug available
RCEP IP chapter analysis
Briefing: Trading Away Health – The Regional Comprehensive Economic Partnership
MSF welcomes Pfizer’s pneumonia vaccine price reduction for children in humanitarian emergencies